- A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans
-
Sargeant J, Henson J, King JA, Yates T, Khunti K, Davies MJ
- KMID: 2458626
- Endocrinol Metab.
- 2019 Sep;34(3):247-262.
- doi: 10.3803/EnM.2019.34.3.247
Weight loss is an important goal in the management of several chronic conditions, including type 2 diabetes mellitus, and pharmacological therapies that aid weight loss are appealing. Glucagon-like peptide-1 receptor... -
- CITED
-
- Close
- SHARE
-
- Close
